Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoko Matsuo

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Cardiovascular Pharmacology|October 27, 2004
Endothelial nitric oxide synthase-independent effects of an ACE inhibitor on coronary flow response to bradykinin in aged miceM A Hassan Talukder, Takako Fujiki, Keiko Morikawa, et al.
The Kurume Medical Journal|March 18, 2017
Factor X Deficiency with Heterozygous Mutations of Novel p.G435S and Known p.G244R in a Patient Presenting with Severe Umbilical HemorrhageYoko Matsuo, Tatsuki Mizuochi, Mitsuo Miho, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 18, 2017
Kidney allograft pyelonephritis caused by Salmonella enterica serovar SchwarzengrundKenta Ito, Haruomi Nishio, Yuji Iwatani, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2024
[Successful immunosuppressive therapy in female hemophilia A developing inhibitor after perioperative administration of factor VIII products]Maki Yamaguchi, Yusuke Takaki, Yoshitaka Yamasaki, et al.
The Journal of Biological Chemistry|July 1, 2006
Cytocidal actions of parasporin-2, an anti-tumor crystal toxin from Bacillus thuringiensisSakae Kitada, Yuichi Abe, Hiroyasu Shimada, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 11, 2022
Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2)Keiji Nogami, Masashi Taki, Tadashi Matsushita, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Cardiovascular Pharmacology|October 27, 2004
Endothelial nitric oxide synthase-independent effects of an ACE inhibitor on coronary flow response to bradykinin in aged miceM A Hassan Talukder, Takako Fujiki, Keiko Morikawa, et al.
The Kurume Medical Journal|March 18, 2017
Factor X Deficiency with Heterozygous Mutations of Novel p.G435S and Known p.G244R in a Patient Presenting with Severe Umbilical HemorrhageYoko Matsuo, Tatsuki Mizuochi, Mitsuo Miho, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 18, 2017
Kidney allograft pyelonephritis caused by Salmonella enterica serovar SchwarzengrundKenta Ito, Haruomi Nishio, Yuji Iwatani, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 6, 2024
[Successful immunosuppressive therapy in female hemophilia A developing inhibitor after perioperative administration of factor VIII products]Maki Yamaguchi, Yusuke Takaki, Yoshitaka Yamasaki, et al.
The Journal of Biological Chemistry|July 1, 2006
Cytocidal actions of parasporin-2, an anti-tumor crystal toxin from Bacillus thuringiensisSakae Kitada, Yuichi Abe, Hiroyasu Shimada, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 11, 2022
Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2)Keiji Nogami, Masashi Taki, Tadashi Matsushita, et al.
Pageof 2